Your browser doesn't support javascript.
loading
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness.
Xie, Ying; Wang, Yazhe; Li, Jing; Hang, Yu; Jaramillo, Lee; Wehrkamp, Cody J; Phillippi, Mary Anne; Mohr, Ashley M; Chen, Yi; Talmon, Geoffrey A; Mott, Justin L; Oupický, David.
Afiliación
  • Xie Y; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Wang Y; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Li J; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Hang Y; Bohemica Pharmaceuticals, LLC, La Vista, NE 68128, USA.
  • Jaramillo L; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Wehrkamp CJ; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Phillippi MA; Bohemica Pharmaceuticals, LLC, La Vista, NE 68128, USA.
  • Mohr AM; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Chen Y; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Talmon GA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Mott JL; Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Oupický D; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Theranostics ; 8(16): 4305-4320, 2018.
Article en En | MEDLINE | ID: mdl-30214622
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Colangiocarcinoma / Receptores CXCR4 / MicroARNs / Nanopartículas / Terapia Molecular Dirigida / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Colangiocarcinoma / Receptores CXCR4 / MicroARNs / Nanopartículas / Terapia Molecular Dirigida / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos